The Trendlines Group Ltd.

Equities

42T

IL0011328858

Investment Management & Fund Operators

Delayed Singapore S.E. Other stock markets 03:59:11 2024-09-12 am EDT			5-day change	1st Jan Change
0.0600 ^SGD	+5.26%		+5.26%	-34.07%

Aug. 28	Trendlines Secures $1.5 Million Investment from Controlling Shareholder	MT
Aug. 27	Vensica Medical Ltd. announced that it expects to receive $0.128 million in funding from Librae Holdings Limited, The Trendlines Group Ltd.	CI

The Trendlines Group Ltd. announced that it expects to receive SGD 4.596 million in funding

July 03, 2024

Trendlines Group Ltd. announced a private placement to issue 76,600,000 common shares at an issue price of SGD 0.06 per share for the gross proceeds of SGD 4,596,000 on July 4, 2024. The transaction will include participation from controlling shareholders, CEO and among others.

Latest news about The Trendlines Group Ltd.

Trendlines Secures $1.5 Million Investment from Controlling Shareholder	Aug. 27	MT
Vensica Medical Ltd. announced that it expects to receive $0.128 million in funding from Librae Holdings Limited, The Trendlines Group Ltd.	Aug. 26	CI
The Trendlines Net Attributable Profit Plummets 64% in H1	Aug. 08	MT
The Trendlines Group Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	Aug. 07	CI
Trendlines Group Updates on Proposed Share Subscription Deal, Portfolio Companies	Aug. 05	MT
Trendlines Group Raising SG$4.4 Million via Subscription Deals; Shares Surge 20%	Jul. 04	MT
The Trendlines Group Ltd. announced that it expects to receive SGD 4.596 million in funding	Jul. 03	CI
AgriG8 Pte Ltd. announced that it has received funding from The Trendlines Group Ltd., Better Bite Ventures	Jun. 09	CI
The Trendlines Group Receives Valid Acceptances and Excess Applications for 67.8 Million Rights Shares	May. 29	MT
Trendlines Group Grants CEO Stock Options	May. 07	MT
Trendlines Group Proposes Rights Issue to Raise SG$4.4 Million	Mar. 26	MT
Singapore Shares Recover at Market Close After Mid-Day Fall; IFAST's Shares Jump 5% as Profit Balloons 917% in Q4 2023	Feb. 22	MT
Trendlines’ Attributable Net Loss Widens in H2 2023; Portfolio Value Decreases	Feb. 22	MT
Trendlines Co-Chair Steps Down; Interim Co-Chair Named	Feb. 22	MT
The Trendlines Group Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 21	CI
The Trendlines Group Ltd. Announces Changes to the Composition of the Board and Its Committees, Effective 8 March 2024	Feb. 21	CI
The Trendlines Group Ltd. Announces Cessation of Kobby Greenberg as CEO Trendlines Innovation Labs	Feb. 13	CI
Trendlines Flags Wider FY2023 Loss After Cancelling Portfolio Acquisition	Feb. 05	MT
Singapore Stocks Lose Further Ground; Seatrium Shares Slip 2% on Cancelation of Wind Farm Project	Jan. 04	MT
Trendlines Group to Report Loss in 2023; Shares Drop 9%	Jan. 03	MT
The Trendlines Group Ltd. Provides Unaudited Consolidated Earnings Guidance for the Year Ended December 31, 2023	Jan. 03	CI
Transcript : The Trendlines Group Ltd. - Shareholder/Analyst Call	Nov. 14
The Trendlines Group Ltd. Appoints Haim Brosh as Interim Chief Financial Officer	23-10-31	CI
The Trendlines Group Ltd. Announces Chief Executive Officer Changes	23-10-31	CI
Trendlines Group's Portfolio Company Receives Letter of Intent for Acquisition	23-10-29	MT

Chart The Trendlines Group Ltd.

Duration

Period

More charts

Company Profile

Trendlines Group Ltd is an Israel-based life sciences innovation commercialization company, which invents, discovers, invests in, partners and incubates innovation based medical and agricultural technologies. It invests principally through four business units: two Israeli government-franchised incubators, Trendlines Medical and Trendlines Agtech, a Singapore incubator, Trendlines Medical Singapore, and an in-house innovation center, Trendlines Labs. The Groupâ s portfolio include more than 50 companies engaged with medical and agricultural technologies and products. The Group is involved in all aspects of its portfolio companies from technology development to business building. The Group in partnerships with entrepreneurs, investors, strategic players, inventors, and governments aims to improve the human condition.

Employees

Sector

Investment Management & Fund Operators

Calendar

2024-09-18 - Extraordinary Shareholders Meeting

More about the company

Income Statement and Estimates

More financial data

Annual profits - Rate of surprise

Company calendar